Reducing the risk of gynecologic cancer in the Lynch syndrome

New England Journal of Medicine

Volumn 354, Issue 3, 2006, Pages 293-295

  Offit, Kenneth ^a   Kauff, Noah D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; PROTEIN MLH1; PROTEIN MSH2; PROTEIN MSH6; TAMOXIFEN;

BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; EARLY MENOPAUSE; EDITORIAL; ENDOMETRIUM CANCER; FAMILIAL CANCER; GENE MUTATION; GENETIC SCREENING; GYNECOLOGIC CANCER; GYNECOLOGIC SURGERY; HUMAN; HYSTERECTOMY; MISMATCH REPAIR; OVARY CANCER; OVARY CARCINOMA; PRIORITY JOURNAL; RISK REDUCTION; SALPINGOOOPHORECTOMY; UROGENITAL TRACT CANCER;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; OVARIAN NEOPLASMS; OVARIECTOMY; RISK;

EID: 30944460907     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe058284     Document Type: Editorial

References (15)

1. Warthin AS. The further study of a cancer family. J Cancer Res 1925;9:279-86.
2. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85.
3. Lynch HT, Lynch JF. Lynch syndrome: history and current status. Dis Markers 2004;20:181-98.
4. Schmeler KM, Lynch HT, Chem L, et al. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 2006;354:261-9.
5. Watson P, Vasen HF, Mecklin JP, Jarvinen H, Lynch HT. The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 1994;96:516-20.
6. Klaren HM, van't Veer LJ, van Leeuwen FE, Rookus MA. Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation. J Natl Cancer Inst 2003;95:941-7.
7. Jemal A, Murray T, Ward E, et al. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30. [Erratum, CA Cancer J Clin 2005;55:259.]
8. Boks DE, Trujillo AP, Voogd AC, Morreau H, Kenter GG, Vasen HF. Survival analysis of endometrial carcinoma associated with hereditary nonpolyposis colorectal cancer. Int J Cancer 2002;102:198-200.
9. Pistorius S, Nagel M, Kruger S, et al. Combined molecular and clinical approach for decision making for surgery in HNPCC patients: a report on three cases in two families. Int J Colorectal Dis 2001;16:402-7.
10. Cuzick J, Powles T, Veronesi U, et al. Overview of the main outcomes in breast-cancer prevention trials. Lancet 2003;361:296-300.
11. Robson ME, Boyd J, Borgen PI, Cody HS III. Hereditary breast cancer. Curr Probl Surg 2001;38:387-480.
12. Watson P, Butzow R, Lynch HT, et al. The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2001;82:223-8.
13. Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003;348:919-32.
14. Rijcken FE, Mourits MJ, Kleibeuker JH, Hollema H, van der Zee AG. Gynecologic screening in hereditary nonpolyposis colorectal cancer. Gynecol Oncol 2003;91:74-80.
15. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.